潤歌(02422.HK)料去年稅後純利增逾35% 股價午後倒升2%後無以為繼
潤歌互動(02422.HK)預計去年稅後純利增逾35%,股價繼今早最多挫16%至1.18元創四個月低喘定後,下午開市倒升2.1%至1.43元無以為繼,現報1.33元,續跌5%,成交增至705萬股,創逾三個月高。
潤歌互動是內地營銷服務提供商。股份去年10月17日以每股0.64元來港上市,首掛日股價倍升(高低見1.67元/1.09元),並於去年11月17日進一步升至3.2元遇阻,之後反覆回落。潤歌中午預告,去年稅後純利不少於6,750萬元人民幣,按年增長不少35%;經調整純利最少8,020萬元人民幣,按年增長最少26.1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.